Evidence map›Paper›PMID 30035577›Full record

ArticleExperimental and clinical psychopharmacology2018

Effects of GluN2B-selective antagonists on delay and probability discounting in male rats: Modulation by delay/probability presentation order.

Justin R Yates, Nicholas A Prior, Marissa R Chitwood, Haley A Day, Jonah R Heidel, Sarah E Hopkins, Brittany T Muncie, Tatiana A Paradella-Bradley, Alexandra P Sestito, Ashley N Vecchiola and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. GABANeuropharmacology · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Justin R YatesDepartment of Psychological Science.
Nicholas A PriorDepartment of Psychological Science.
Marissa R ChitwoodDepartment of Psychological Science.
Haley A DayDepartment of Psychological Science.
Jonah R HeidelDepartment of Psychological Science.
Sarah E HopkinsDepartment of Psychological Science.
Brittany T MuncieDepartment of Psychological Science.
Tatiana A Paradella-BradleyDepartment of Psychological Science.
Alexandra P SestitoDepartment of Psychological Science.
Ashley N VecchiolaDepartment of Psychological Science.
Emily E WellsDepartment of Psychological and Brain Sciences.

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ERIC C ROUCHKA · 2012 to 2026
$60.1M
College of Arts and SciencesNational Institute of General Medical SciencesNIGMS NIH HHS P20 GM103436Northern Kentucky University
6 · The paper itself

Abstract

The contribution of the GluN2B subunit of the NMDA receptor to impulsivity has recently been examined. Ro 63-1908, a highly selective antagonist for the GluN2B, decreases impulsive choice. Because the order in which delays are presented modulates drug effects in discounting procedures, one goal of the current study was to determine the effects of Ro 63-1908 in delay discounting procedures in which the delays to obtaining the large reinforcer either increase or decrease across the session. We also determined if Ro 63-1908 differentially alters risky choice in probability discounting procedures that use ascending/descending schedules. Male rats were trained in either delay (

Indexed as

AnimalsChoice BehaviorConditioning, OperantDelay DiscountingImpulsive BehaviorMalePhenolsPiperidinesProbabilityRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateReinforcement, PsychologyNR2B NMDA receptorPhenolsPiperidinesReceptors, N-Methyl-D-AspartateRo 631908traxoprodil mesylate

Identifiers

PMID30035577
PMCPMC6283694
OpenAlexW2883677784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.